Analysts who follow Evogene Ltd (EVGN) on average expect it to rise 217.12% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns EVGN an Analyst Ranking of 78, which means it ranks higher than 78 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Evogene Ltd Stock Today?
Evogene Ltd (EVGN) stock is higher by 10.26% while the S&P 500 is down -0.36% as of 2:44 PM on Tuesday, Mar 30. EVGN has risen $0.44 from the previous closing price of $4.29 on volume of 1,260,450 shares. Over the past year the S&P 500 has risen 50.64% while EVGN has risen 337.96%. EVGN lost -$0.81 per share the over the last 12 months.
Click Here to get the full report on Evogene Ltd (EVGN) Stock.
